![Alison Long](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Long
Direktör/Styrelseledamot på
TAYSHA GENE THERAPIES, INC.
Förmögenhet: 746 535 $ per 2026-05-31
Profil
Alison Long is currently an Independent Director at Taysha Gene Therapies, Inc. since 2023 and Chief Medical Officer at Flightpath Biosciences, Inc. since 2023.
Former roles include Chief Medical Officer at Anokion SA from 2022 to 2023, Chief Medical Officer at Kaleido Biosciences, Inc. from 2021 to 2022, Chief Medical Officer & Senior Vice President at Freeline Therapeutics Holdings Ltd. in 2021, and Head-Clinical R&D at Spark Therapeutics, Inc. from 2019 to 2020.
Education includes a doctorate from George Mason University and an undergraduate degree from the University of the Witwatersrand.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-01 | 127 178 ( 0,05 % ) | 746 535 $ | 2026-05-31 |
Aktiva positioner av Alison Long
| Företag | Position | Start |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Direktör/Styrelseledamot | 2023-11-01 |
Flightpath Biosciences, Inc.
 Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Teknisk/Vetenskaplig/F&U Direktör | 2023-01-01 |
Tidigare kända positioner av Alison Long
| Företag | Position | Slut |
|---|---|---|
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Teknisk/Vetenskaplig/F&U Direktör | 2023-01-01 |
| KALEIDO BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-04-01 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Teknisk/Vetenskaplig/F&U Direktör | 2021-11-01 |
| SPARK THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-06-01 |
Alison Longs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
12
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
